Differences in the concentrations df small, anionic, antimicrobial peptides in bronchoalveolar lavage fluid and in respiratory epithelia of patients with and without cystic fibrosis

被引:29
作者
Brogden, KA
Ackermann, MR
McCray, PB
Huttner, KM
机构
[1] ARS, Resp & Neurol Dis Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA
[2] Iowa State Univ, Dept Vet Pathobiol, Ames, IA 50011 USA
[3] Univ Iowa Hosp & Clin, Dept Pediat, Allergy Pulm Div, Iowa City, IA 52242 USA
[4] Childrens Hosp, Dept Med, Joint Program Neonatol, Boston, MA 02115 USA
关键词
D O I
10.1128/IAI.67.8.4256-4259.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Affinity-purified rabbit polyclonal (PAB96-1) and mouse monoclonal (1G9-1C2) antibodies to synthetic H-DDDDDDD-ON, an antimicrobial anionic peptide (AP) originally isolated from ovine pulmonary surfactant, were prepared and used to assess the concentrations of AP-like molecules in human respiratory tract samples. In bronchoalveolar lavage fluids, concentrations of AP-like molecules measured by enzyme-linked imnmunosorbent assay were significantly lower in 13 patients with cystic fibrosis (CF) (mean +/- standard deviation [SD], 0.78 +/- 0.46 mM) than in 34 patients without CF (1.30 +/- 0.66 mM) (P = 0.01), In pulmonary tissues of three patients without CF, very little antigen was stained in the apical cytoplasm of the bronchial and bronchiolar epithelium yet robust staining was seen in the alveolar epithelium. In pulmonary tissues of three patients with CF, robust staining of antigen was seen in the apical cytoplasm of the bronchial and bronchiolar epithelium yet no staining was seen in the alveolar epithelium. These results show that AP-like molecules are present in healthy human respiratory tract samples and differ in concentration and location of expression in patients with and without CF.
引用
收藏
页码:4256 / 4259
页数:4
相关论文
共 15 条
[1]   Bactericidal action of lysozymes attached with various sizes of hydrophobic peptides to the C-terminal using genetic modification [J].
Arima, H ;
Ibrahim, HR ;
Kinoshita, T ;
Kato, A .
FEBS LETTERS, 1997, 415 (01) :114-118
[2]   The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface [J].
Bals, R ;
Wang, XR ;
Zasloff, M ;
Wilson, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9541-9546
[3]   Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica [J].
Brogden, KA ;
DeLucca, AJ ;
Bland, J ;
Elliott, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :412-416
[4]   Detection of anionic antimicrobial peptides in ovine bronchoalveolar lavage fluid and respiratory epithelium [J].
Brogden, KA ;
Ackermann, M ;
Huttner, KM .
INFECTION AND IMMUNITY, 1998, 66 (12) :5948-5954
[5]   Small, anionic, and charge-neutralizing propeptide fragments of zymogens are antimicrobial [J].
Brogden, KA ;
Ackermann, M ;
Huttner, KM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1615-1617
[6]   Cystic fibrosis [J].
Davis, PB ;
Drumm, M ;
Konstan, MW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) :1229-1256
[7]   ISOLATION OF AN ANTIBACTERIAL PEPTIDE FROM HUMAN-LUNG LAVAGE FLUID [J].
ELLISON, RT ;
BOOSE, D ;
LAFORCE, FM .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (06) :1123-1129
[8]   Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis [J].
Goldman, MJ ;
Anderson, GM ;
Stolzenberg, ED ;
Kari, UP ;
Zasloff, M ;
Wilson, JM .
CELL, 1997, 88 (04) :553-560
[9]   Antibacterial activity of antileukoprotease [J].
Hiemstra, PS ;
Maassen, RJ ;
Stolk, J ;
HeinzelWieland, R ;
Steffens, GJ ;
Dijkman, JH .
INFECTION AND IMMUNITY, 1996, 64 (11) :4520-4524
[10]   Inhibition of bacterial growth by synthetic SP-B1-78 peptides [J].
Kaser, MR ;
Skouteris, GG .
PEPTIDES, 1997, 18 (09) :1441-1444